CSRP2, TIMP-1, and SM22α promoter fragments direct hepatic stellate cell-specific transgene expression in vitro, but not in vivo

Liver International

Volumn 24, Issue 1, 2004, Pages 69-79

  Herrmann, Jens ^a   Arias, Monica ^a   Van de Leur, Eddy ^a   Gressner, Axel M ^a   Weiskirchen, Ralf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Adenovirus (Ad); Cysteine and glycine rich protein 2; Gene transfer; Hepatic stellate cell; Liver fibrosis; Myofibroblast; Smooth muscle specific gene; Tissue inhibitor of metalloproteinases 1

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; LIM PROTEIN; MUSCLE PROTEIN; PROTEIN SM22 ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSGELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; FIBROGENESIS; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PROMOTER REGION; RAT; REPORTER GENE; STELLATE CELL; TRANSGENE;

EID: 1542709516     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.00891.x     Document Type: Article

References (47)

1. Friedman S L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-50.
2. Gressner A M, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-β in hepatic fibrosis. Front Biosci 2002; 7: 793-807.
3. Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H. Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 1999; 96: 2345-9.
4. 2-macroglobulin reduces paracrine- and autocrine-stimulated matrix synthesis of cultured rat hepatic stellate cells. Eur J Clin Invest 1999; 29: 519-28.
5. Arias M, Lahme B, Van de Leur E, Gressner A M, Weiskirchen R. Adenoviral delivery of an antisense RNA complementary to the 3′ coding sequence of transforming growth factor-β1 inhibits fibrogenic activities of hepatic stellate cells. Cell Growth Differ 2002; 23: 265-73.
6. Iredale J P, Benyon R C, Arthur M J, Ferris W F, Alcolado R, Winwood P J, Clark N, Murphy G. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996; 24: 176-84.
7. Bahr M J, Vincent K J, Arthur M J, Fowler A V, Smart D E, Wright M C, Clark I M, Benyon R C, Iredale J P, Mann D A. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Hepatology 1999; 29: 839-48.
8. Lees-Miller J P, Heeley D H, Smillie L B. An abundant and novel protein of 22 kDa (SM22) is widely distributed in smooth muscles. Purification from bovine aorta. Biochem J 1987; 244: 705-9.
9. Duband J L, Gimona M, Scatena M, Sartore S, Small J V. Calponin and SM22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation 1993; 55: 1-11.
10. Li L, Miano J M, Mercer B, Olson E N. Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 1996; 132: 849-59.
11. Giannini G, Alesse E, di Marcotullio L, Zazzeroni F, Gallo R, Zani M, Frati L, Screpanti I, Gulino A. EGF regulates a complex pattern of gene expression and represses smooth muscle differentiation during the neurotypic conversion of the neural-crest-derived TC-1S cell line. Exp Cell Res 2001; 264: 353-62.
12. Hirschi K K, Rohovsky S A, D'Amore P A. PDGF, TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998; 141: 805-14.
13. 2 stress triggers a release of transforming growth factor-β1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem 2001; 276: 2531-7.
14. Weiskirchen R, Abriss B, Arias M, Kneifel J, Van de Leur E, Weiskirchen S, Gressner A M. Experimental approaches to antifibrotic strategies using gene transfer. In: Gressner A M, Heinrich P C, Mater S, eds. Progress in Gastroenterology and Hepatology; Cytokines in Liver Injury and Repair. Dordrecht. The Netherlands: Kluwer Academic Publishers, 2002; 335-53.
15. Weiskirchen R, Moser M, Weiskirchen S, Erdel M, Dahmen S, Buettner R, Gressner A M. LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1. Biochem J 2001; 359:485-96.
16. de Leeuw A M, McCarthy S P, Geerts A, Knook D L. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology 1984; 4: 392-403.
17. Fehrenbach H, Weiskirchen R, Kasper M, Greesner A M. Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology 2001; 34: 943-52.
18. Schafer S, Zerbe O, Gressner A M. The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 1987; 7: 680-7.
19. Gressner A M, Zerbe O. Kupffer cell-mediated induction of synthesis and secretion of proteoglycans by rat liver fat-storing cells in culture. J Hepatol 1987; 5: 299-310.
20. Seglen P O. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29-83.
21. Weiskirchen R, Gressner A M. The cysteine- and glycine-rich LIM domain protein CRP2 specifically interacts with a novel human protein (CRP2BP). Biochem Biophys Res Commun 2000; 274: 655-63.
22. Weiskirchen R, Kneifel J, Weiskirchen S, van de Leur E, Kunz D, Gressner A M. Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts. BMC Cell Biol 2000; 1: 4.
23. Weiskirchen R, Erdel M, Utermann G, Bister K. Cloning, structural analysis, and chromosomal localization of the human CSRP2 gene encoding the LIM domain protein CRP2. Genomics 1997; 44: 83-93.
24. Kemp P R, Osboum J K, Grainger D J, Metcalfe J C. Cloning and analysis of the promoter region of the rat SM22α gene. Biochem J 1995; 310: 1037-43.
25. Bugno M, Graeve L, Gatsios P, Koj A, Heinrich P C, Travis J, Kordula T. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res 1995; 23: 5041-7.
26. McGrory W J, Bautista D S, Graham F L. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 1988; 163: 614-7.
27. 4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. Lab Invest 1993; 69: 210-6.
28. Jain M K, Kashiki S, Hsieh C M, Layne M D, Yet S F, Sibinga N E, Chin M T, Feinberg M W, Woo I, Maas R L, Haber E, Lee M E. Embryonic expression suggests an important role for CRP2/SmLIM in the developing cardiovascular system. Circ Res 1998; 83: 980-5.
29. Chang D F, Belaguli N S, Iyer D, Roberts W B, Wu S P, Dong X R, Marx J G, Moore M S, Beckerle M C, Majesky M W, Schwartz R J. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev Cell 2003; 4: 107-18.
30. Louis H A, Pino J D, Schmeichel K L, Pomiès P, Beckerle M C. Comparison of three members of the cysteine-rich protein family reveals functional conservation and divergent patterns of gene expression. J Biol Chem 1997; 272: 27484-91.
31. Weiskirchen R, Bister K. Suppression in transformed avian fibroblasts of a gene (crp) encoding a cysteine-rich protein containing LIM domains. Oncogene 1993; 8: 2317-24.
32. Jain M K, Fujita K P, Hsieh C M, Endege W O, Sibinga N E, Yet S F, Kashiki S, Lee W S, Perella M A, Haber E, Lee M E. Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells. J Biol Chem 1996; 271: 10194-9.
33. Shanahan C M, Weissberg P L, Metcalfe J C. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 1993; 73: 193-204.
34. Clark I M, Rowan A D, Edwards D R, Bech-Hansen T, Mann D A, Bahr M J, Cawston T E. Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem J 1997; 324: 611-7.
35. Trim J E, Samra S K, Arthur M J, Wright M C, Mcaulay M, Beri R, Mann D A. Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. J Biol Chem 2000; 275: 6657-63.
36. Hall M C, Young D A, Waters J G, Rowan A D, Chantry A, Edwards D R, Clark I M. The comparative role of AP1 and Smad factors in the regulation of TIMP-1 and MMP-1 gene expression by TGF-β1. J Biol Chem 2003; 278: 10304-13.
37. Smart D E, Vincent K J, Arthur M J, Eickelberg O, Castellazzi M, Mann J, Mann D A. JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J Biol Chem 2001; 276: 24414-21.
38. Solway J, Seltzer J, Samaha F F, Kim S, Alger L E, Niu Q, Morrisey E E, Ip, H S, Parmacek M S. Structure and expression of a smooth muscle cell-specific gene, SM22α. J Biol Chem 1995; 270: 13460-9.
39. Strobeck M, Kim S, Zhang J C, Clendenin C, Du K L, Parmacek M S. Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells. J Biol Chem 2001; 276: 16418-24.
40. Adam P J, Regan C P, Hautmann M B, Owens G K. Positive- and negative-acting Krüppel-like transcription factors bind a transforming growth factor β control element required for expression of the smooth muscle cell differentiation marker SM22α in vivo. J Biol Chem 2000; 275: 37798-806.
41. Moessler H, Mericskay M, Li Z, Nagl S, Paulin D, Small J V. The SM22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 1996; 122: 2415-25.
42. Gressner A M, Lahme B, Mannherz H G, Polzar B. TGF-β-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 1997; 26: 1079-92.
43. Quandt K, Frech K, Karas H, Wingender E, Werner T MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878-84.
44. Yu Q, Shao R, Qian H S, George S E, Rockey D C. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. J Clin Invest 2000; 105: 741-8.
45. Yu Q, Que L G, Rockey D C. Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver. Am J Physiol Gastrointest Liver Physiol 2002; 282: G565-72.
46. Liu H S, Jan M S, Chou C K, Chen P H, Ke N J. Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 1999; 260: 712-7.
47. Endemann G, Schechtman D, Mochly-Rosen D. Cytotoxicity of pEGFP vector is due to residues encoded by multiple cloning site. Anal Biochem 2003; 313: 345-7.